Diabetes Mellitus and COVID-19: Review Article

被引：38
作者：
Nassar, Mahmoud [1 ]
Daoud, Ahmed [2 ]
Nso, Nso [1 ]
Medina, Luis [1 ]
Ghernautan, Victoria [1 ]
Bhangoo, Harangad [1 ]
Nyein, Andrew [3 ]
Mohamed, Mahmoud [4 ]
Alqassieh, Ahmed [5 ]
Soliman, Karim [6 ]
Alfishawy, Mostafa [7 ]
Sachmechi, Issac [8 ]
Misra, Anoop [9 ,10 ,11 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dept Med, NYC Hlth Hosp Queens, New York, NY 10029 USA
[2] Cairo Univ, Internal Med Dept, Fac Med, Cairo, Egypt
[3] New York Inst Technol, Coll Osteopath Med, New York, NY USA
[4] North Mississippi Med Ctr, Med Dept, Tupelo, MS USA
[5] Med Univ South Carolina, Dept Surg, Charleston, SC 29425 USA
[6] Med Univ South Carolina, Dept Med & Surg, Div Nephrol, Charleston, SC 29425 USA
[7] Infect Dis Consultants & Acad Researchers Egypt I, Cairo, Egypt
[8] Icahn Sch Med Mt Sinai, Dept Med, Div Endocrinol, NYC Hlth Hosp Queens, New York, NY 10029 USA
[9] Fortis C DOC Ctr Excellence Diabet Metab Dis & En, New Delhi, India
[10] Natl Diabet Obes & Cholesterol Fdn N DOC, New Delhi, India
[11] Diabet Fdn India DFI, New Delhi, India
来源：
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS | 2021年 / 15卷 / 06期
关键词：
Diabetes mellitus; COVID-19; Management; Pathophysiology; Risk factor; Type; 1; Typ; 2; CRITICALLY-ILL PATIENTS; CLINICAL CHARACTERISTICS; CORONAVIRUS; OUTCOMES; DISEASE; TYPE-1; ASSOCIATION; MORTALITY; THERAPY; BINDING;
D O I：
10.1016/j.dsx.2021.102268
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Background and aims: We aim to cover most of the current evidence on the mutual effect of diabetes & COVID-19 infection on each other and the management of the COVID-19 patients with diabetes. Methods: We utilized databases to review the current evidence related to diabetes mellitus and COVID19. Results: We discussed the most recent evidence of diabetes milieus and COVID-19 regarding risk factors, management, complications, and telemedicine. Conclusion: Diabetes mellitus is associated with a significant risk of complications, extended hospital stays, and mortality in COVID-19 infected patients. (C) 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页数：8
相关论文
共 74 条
  • [1] Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes
    Alessi, Janine
    de Oliveira, Giovana B.
    Schaan, Beatriz D.
    Telo, Gabriela H.
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2020, 12 (01)
  • [2] New-onset Type 1 Diabetes Mellitus with Diabetic Ketoacidosis and Pancreatitis in a Patient with COVID-19
    Alfishawy, Mostafa
    Nassar, Mahmoud
    Mohamed, Mahmoud
    Fatthy, Moataz
    Elmessiery, Riem M.
    [J]. SCIENTIFIC AFRICAN, 2021, 13
  • [3] Influenza co-infection associated with severity and mortality in COVID-19 patients
    Alosaimi, Bandar
    Naeem, Asif
    Hamed, Maaweya E.
    Alkadi, Haitham S.
    Alanazi, Thamer
    Al Rehily, Sanaa Saad
    Almutairi, Abdullah Z.
    Zafar, Adnan
    [J]. VIROLOGY JOURNAL, 2021, 18 (01)
  • [4] Could a family history of type 2 diabetes be a risk factor to the endothelial damage in the patient with COVID-19?
    Alvarado-Vasquez, Noe
    [J]. MEDICAL HYPOTHESES, 2021, 146
  • [5] [Anonymous], 2020, LANCET HAEMATOL, V7, pE425, DOI 10.1016/S2352-3026(20)30151-4
  • [6] COVID-19 in people with diabetes: understanding the reasons for worse outcomes
    Apicella, Matteo
    Campopiano, Maria Cristina
    Mantuano, Michele
    Mazoni, Laura
    Coppelli, Alberto
    Prato, Stefano Del
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (09) : 782 - 792
  • [7] Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome
    Arabi, Yaseen M.
    Mandourah, Yasser
    Al-Hameed, Fahad
    Sindi, Anees A.
    Almekhlafi, Ghaleb A.
    Hussein, Mohamed A.
    Jose, Jesna
    Pinto, Ruxandra
    Al-Omari, Awad
    Kharaba, Ayman
    Almotairi, Abdullah
    Al Khatib, Kasim
    Alraddadi, Basem
    Shalhoub, Sarah
    Abdulmomen, Ahmed
    Qushmaq, Ismael
    Mady, Ahmed
    Solaiman, Othman
    Al-Aithan, Abdulsalam M.
    Al-Raddadi, Rajaa
    Ragab, Ahmed
    Balkhy, Hanan H.
    Al Harthy, Abdulrahman
    Deeb, Ahmad M.
    Al Mutairi, Hanan
    Al-Dawood, Abdulaziz
    Merson, Laura
    Hayden, Frederick G.
    Fowler, Robert A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (06) : 757 - 767
  • [8] Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study
    Barron, Emma
    Bakhai, Chirag
    Kar, Partha
    Weaver, Andy
    Bradley, Dominique
    Ismail, Hassan
    Knighton, Peter
    Holman, Naomi
    Khunti, Kamlesh
    Sattar, Naveed
    Wareham, Nicholas J.
    Young, Bob
    Valabhji, Jonathan
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (10) : 813 - 822
  • [9] Type 2 Diabetes and its Impact on the Immune System
    Berbudi, Afiat
    Rahmadika, Nofri
    Tjahjadi, Adi Imam
    Ruslami, Rovina
    [J]. CURRENT DIABETES REVIEWS, 2020, 16 (05) : 442 - 449
  • [10] Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: A systematic analysis of published clinical trials
    Bettge, Karolin
    Kahle, Melanie
    Abd El Aziz, Mirna S.
    Meier, Juris J.
    Nauck, Michael A.
    [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (03) : 336 - 347
12345678